BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6985647)

  • 1. Capping and adenosine metabolism. Genetic and pharmacologic studies.
    Braun J; Rosen FS; Unanue ER
    J Exp Med; 1980 Jan; 151(1):174-83. PubMed ID: 6985647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of lymphocyte function by 9-deazaadenosine.
    Zimmerman TP; Deeprose RD; Wolberg G; Stopford CR; Duncan GS; Miller WH; Miller RL; Lim MI; Ren WY; Klein RS
    Biochem Pharmacol; 1983 Apr; 32(7):1211-7. PubMed ID: 6303353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two distinct mechanisms for redistribution of lymphocyte surface macromolecules. II. Contrasting effects of local anesthetics and a calcium ionophore.
    Braun J; Fujiwara K; Pollard TD; Unanue ER
    J Cell Biol; 1978 Nov; 79(2 Pt 1):419-26. PubMed ID: 363728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Animal model for immune dysfunction associated with adenosine deaminase deficiency.
    Tedde A; Balis ME; Ikehara S; Pahwa R; Good RA; Trotta PP
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4899-903. PubMed ID: 6968908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine metabolism in phytohemagglutinin-stimulated human lymphocytes.
    Snyder FF; Mendelsohn J; Seegmiller JE
    J Clin Invest; 1976 Sep; 58(3):654-66. PubMed ID: 956393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 2'-deoxycoformycin infusion on S-adenosylhomocysteine hydrolase and the amount of S-adenosylhomocysteine and related compounds in tissues of mice.
    Helland S; Ueland PM
    Cancer Res; 1983 Sep; 43(9):4142-7. PubMed ID: 6603264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactivation of S-adenosylhomocysteine hydrolase activity in cells exposed to 9-beta-D-arabinofuranosyladenine.
    Helland S; Ueland PM
    Cancer Res; 1982 Jul; 42(7):2861-6. PubMed ID: 6979384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding thermodynamics of the transition state analogue coformycin and of the ground state analogue 1-deazaadenosine to bovine adenosine deaminase.
    Castro C; Britt BM
    J Enzyme Inhib; 2001; 16(3):217-32. PubMed ID: 11697042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of adenosine deaminase in lymphocyte proliferation.
    Hovi T; Smyth JF; Allison AC; Williams SC
    Clin Exp Immunol; 1976 Mar; 23(3):395-403. PubMed ID: 133008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-immunoglobulin, cytoplasmic free calcium, and capping in B lymphocytes.
    Pozzan T; Arslan P; Tsien RY; Rink TJ
    J Cell Biol; 1982 Aug; 94(2):335-40. PubMed ID: 6809769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand-induced movement of lymphocyte membrane macromolecules. V. Capping, cell movement, and microtubular function in normal and lectin-treated lymphocytes.
    Unanue ER; Karnovsky MJ
    J Exp Med; 1974 Nov; 140(5):1207-20. PubMed ID: 4547538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of maturation of human precursor lymphocytes by coformycin, an inhibitor of the enzyme adenosine deaminase.
    Ballet JJ; Insel R; Merler E; Rosen FS
    J Exp Med; 1976 May; 143(5):1271-6. PubMed ID: 1262787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capping of cholera toxin-ganglioside GM1 complexes on mouse lymphocytes is accompanied by co-capping of alpha-actinin.
    Kellie S; Patel B; Pierce EJ; Critchley DR
    J Cell Biol; 1983 Aug; 97(2):447-54. PubMed ID: 6684122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Order of events leading to surface immunoglobulin capping: analysis of a transmembrane signal.
    Young-Karlan BR; Ashman RF
    J Immunol; 1981 Sep; 127(3):1177-81. PubMed ID: 6790615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic membrane defect and the inhibition of lymphocyte capping in Duchenne muscular dystrophy.
    Goldsmith BM; Gruemer HD
    Clin Chim Acta; 1987 Apr; 164(1):33-46. PubMed ID: 3581480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S-Adenosylhomocysteine accumulation and selective cytotoxicity in cultured T- and B-lymphocytes.
    Palella TD; Schatz RA; Wilens TE; Fox IH
    J Lab Clin Med; 1982 Aug; 100(2):269-78. PubMed ID: 6980250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine-mediated killing of cultured epithelial cancer cells.
    Barry CP; Lind SE
    Cancer Res; 2000 Apr; 60(7):1887-94. PubMed ID: 10766176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of the myocardial actions of adenosine in the presence of coformycin, a specific inhibitor of adenosine deaminase.
    Szentmiklósi AJ; Németh M; Cseppentö A; Szegi J; Papp JG; Szekeres L
    Arch Int Pharmacodyn Ther; 1982 Apr; 256(2):236-52. PubMed ID: 7103613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of T cell activation by an inhibitor of S-adenosyl-L-homocysteine hydrolase.
    Wolos JA; Frondorf KA; Davis GF; Jarvi ET; McCarthy JR; Bowlin TL
    J Immunol; 1993 Apr; 150(8 Pt 1):3264-73. PubMed ID: 8468468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cap formation by various ligands on lymphocytes shows the same dependence on high cellular ATP levels.
    Pozzan T; Corps AN; Montecucco C; Hesketh TR; Metcalfe JC
    Biochim Biophys Acta; 1980 Nov; 602(3):558-66. PubMed ID: 6776985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.